BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24108104)

  • 41. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.
    Ayers JI; Fromholt SE; O'Neal VM; Diamond JH; Borchelt DR
    Acta Neuropathol; 2016 Jan; 131(1):103-14. PubMed ID: 26650262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
    Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatocyte growth factor therapy for amyotrophic lateral sclerosis].
    Aoki M
    Brain Nerve; 2012 Mar; 64(3):245-54. PubMed ID: 22402718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gene therapy of ALS with RNA interference].
    Yokota T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.
    Lepore AC; Haenggeli C; Gasmi M; Bishop KM; Bartus RT; Maragakis NJ; Rothstein JD
    Brain Res; 2007 Dec; 1185():256-65. PubMed ID: 17963733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
    Alisky JM; Davidson BL
    Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1
    Wang W; Duan W; Wang Y; Wen D; Liu Y; Li Z; Hu H; Cui H; Cui C; Lin H; Li C
    Neurochem Res; 2017 Apr; 42(4):986-996. PubMed ID: 28025800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
    D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
    J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.
    Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A
    Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of chaperone activity is a shared property of several Cu,Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis.
    Tummala H; Jung C; Tiwari A; Higgins CM; Hayward LJ; Xu Z
    J Biol Chem; 2005 May; 280(18):17725-31. PubMed ID: 15753080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA interference and amyotrophic lateral sclerosis.
    Rizvanov AA; Gulluoglu S; Yalvaç ME; Palotás A; Islamov RR
    Curr Drug Metab; 2011 Sep; 12(7):679-83. PubMed ID: 21740381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
    Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model.
    Saito Y; Yokota T; Mitani T; Ito K; Anzai M; Miyagishi M; Taira K; Mizusawa H
    J Biol Chem; 2005 Dec; 280(52):42826-30. PubMed ID: 16221675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.